Carregant...
Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials
INTRODUCTION: Venous thromboembolic events (VTE) are a significant cause of death in patients with cancer. The incidence of VTE is not well characterized in early phase clinical trials of novel antineoplastic agents, or in hepatic dysfunction studies designed for patients with varying degrees of liv...
Guardat en:
| Publicat a: | Thromb Res |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4679432/ https://ncbi.nlm.nih.gov/pubmed/26493604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2015.10.024 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|